NYSE:HQL

abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis

abrdn Life Sciences Investors logo
$17.54 -0.08 (-0.45%)
As of 02:35 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About abrdn Life Sciences Investors Stock (NYSE:HQL)

Advanced

Key Stats

Today's Range
$17.48
▼
$17.74
50-Day Range
$16.74
▼
$20.32
52-Week Range
$15.66
▼
$22.67
Volume
124,700 shs
Average Volume
128,282 shs
Market Capitalization
$533.36 million
P/E Ratio
N/A
Dividend Yield
12.77%
Price Target
N/A
Consensus Rating
N/A

Company Overview

abrdn Life Sciences Investors is a non-diversified, closed-end investment fund focused on companies in the life sciences and health care sectors. Rather than developing or selling products itself, the fund invests in businesses involved in areas such as biotechnology, pharmaceuticals, medical devices and related services.

The fund seeks long-term capital appreciation through a portfolio that can include both publicly traded and privately held companies. Its investments may span U.S. and international markets.

Previously known as Tekla Life Sciences Investors, the fund adopted its current name after abrdn became its investment adviser. Its portfolio is managed by abrdn, an asset management firm.

AI Generated. May Contain Errors.

Receive HQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HQL Stock News Headlines

abrdn Life Sciences Investors declares $1.50 dividend
Every Starlink dish pays this stock
There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.tc pixel
HQL: The Rally That Makes Growth Harder (Rating Downgrade)
abrdn Life Sciences Investors Q2 2026 Commentary
abrdn Life Sciences Investors Q1 2026 Commentary
HQL: Attractive Outlook With Growth Of GLP-1 Market
See More Headlines

HQL Stock Analysis - Frequently Asked Questions

abrdn Life Sciences Investors' stock was trading at $16.79 at the start of the year. Since then, HQL stock has increased by 4.7% and is now trading at $17.5750.

Top institutional investors of abrdn Life Sciences Investors include Flagship Harbor Advisors LLC (1.37%), Allspring Global Investments Holdings LLC (1.37%), Advisors Asset Management Inc. (0.69%) and Formidable Asset Management LLC (0.55%). Insiders that own company stock include Saba Capital Management, LP, Kathleen Goetz, Rose Dimartino and Todd Reit.
View institutional ownership trends
.

Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that abrdn Life Sciences Investors investors own include abrdn Healthcare Investors (HQH), Enterprise Products Partners (EPD), AT&T (T), NVIDIA (NVDA), Western Asset Emerging Markets Debt Fund (EMD), Ares Capital (ARCC) and Reaves Utility Income Fund (UTG).

Company Calendar

Today
11/18/2026
Record date for 1/12 Dividend
11/20/2026
Ex-Dividend for 1/12 Dividend
11/20/2026
Record date for 11/30 Dividend
11/20/2026
Ex-Dividend for 11/30 Dividend
11/20/2026
Dividend Payable
11/30/2026
Dividend Payable
1/12/2027
Fiscal Year End
9/30/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Finance
Industry
Capital Markets
Sub-Industry
N/A
Current Symbol
NYSE:HQL
CIK
884121
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$198.93 million
Price / Sales
2.68
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
30,408,000
Free Float
27,349,000
Market Cap
$533.36 million
Optionable
Not Optionable
Beta
0.79
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NYSE:HQL) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners